Adage Capital Partners’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-153,933
| Closed | -$791K | – | 880 |
|
|
2024
Q1 | $791K | Sell |
153,933
-50,000
| -25% | -$257K | ﹤0.01% | 796 |
|
|
2023
Q4 | $1.17M | Sell |
203,933
-50,000
| -20% | -$287K | ﹤0.01% | 758 |
|
|
2023
Q3 | $1.21M | Hold |
253,933
| – | – | ﹤0.01% | 759 |
|
|
2023
Q2 | $1.08M | Sell |
253,933
-33,100
| -12% | -$141K | ﹤0.01% | 764 |
|
|
2023
Q1 | $1.52M | Hold |
287,033
| – | – | ﹤0.01% | 782 |
|
|
2022
Q4 | $1.8M | Sell |
287,033
-60,000
| -17% | -$377K | ﹤0.01% | 821 |
|
|
2022
Q3 | $3.66M | Sell |
347,033
-25,000
| -7% | -$264K | 0.01% | 812 |
|
|
2022
Q2 | $2.02M | Sell |
372,033
-237,034
| -39% | -$1.29M | ﹤0.01% | 879 |
|
|
2022
Q1 | $5.59M | Hold |
609,067
| – | – | 0.01% | 819 |
|
|
2021
Q4 | $9.19M | Hold |
609,067
| – | – | 0.02% | 724 |
|
|
2021
Q3 | $14.5M | Buy |
+609,067
| New | +$14.5M | 0.03% | 579 |
|